Journal Info

Journal Info

副标题

For Authors

For Authors

副标题

For Reviewers

For Reviewers

副标题

2025, Vol. 29 ›› Issue (36): 7719-7727

Comparison of osteogenic potential in STRO-1 positive and negative bone marrow mesenchymal stem cells

Zhou Wanlin1, He Bin2, Shen Xiongcheng1, Huang Kun1, Tian Renyuan1, Yuan Ye1, Huang Wenliang3   

  1. 1Department of Orthopedics, Third Affiliated Hospital of Zunyi Medical University (First People’s Hospital of Zunyi City), Zunyi 563000, Guizhou Province, China; 2Department of Orthopedics, Honghuagang District People’s Hospital of Zunyi City, Zunyi 563000, Guizhou Province, China; 3Department of Orthopedics, Moutai Hospital of Guizhou Province, Renhuai 564500, Guizhou Province, China

  • Received:2024-09-23 Accepted:2024-11-14 Online:2025-12-28 Published:2025-03-03

  • Contact: Huang Wenliang, MS, Chief physician, Department of Orthopedics, Moutai Hospital of Guizhou Province, Renhuai 564500, Guizhou Province, China

  • About author:Zhou Wanlin, Master candidate, Physician, Department of Orthopedics, Third Affiliated Hospital of Zunyi Medical University (First People’s Hospital of Zunyi City), Zunyi 563000, Guizhou Province, China

  • Supported by:

    Guizhou Provincial Science and Technology Plan Project, No. ZK[2021]387 (to HWL); Guizhou Provincial Science and Technology Plan Project, No. LC[2024]019 (to HWL); Guizhou Provincial Health Commission Science and Technology Fund Project, No. gzwjk2024-410 (to SXC); Guizhou Provincial Health Commission Science and Technology Fund Project, No. gzwjk2020-1-131 (to HB)


Abstract: BACKGROUND: With aging, the regenerative capacity and differentiation function of bone marrow mesenchymal stem cells progressively decline, reducing bone tissue repair efficacy. Thus, identifying bone marrow mesenchymal stem cell subpopulations with enhanced osteogenic potential is of significant importance for advancing bone tissue engineering.
OBJECTIVE: To evaluate the osteogenic differentiation potential differences between STRO-1 positive and negative bone marrow mesenchymal stem cells under osteogenic induction conditions.
METHODS: SD rat bone marrow mesenchymal stem cells were isolated and cultured. The expression of CD29, CD45, CD90, and STRO-1 was identified via flow cytometry and immunofluorescence. Immunomagnetic cell sorting was used to separate STRO-1 positive and negative bone marrow mesenchymal stem cells. The cells of two groups were subjected to osteogenic induction for 7 and 14 days. qRT-PCR and western blotting were performed to analyze differences in osteogenesis-related gene expression (Collagen I, Runt-related transcription factor 2, osteoprotegerin, and osteocalcin) and protein levels. Alizarin red staining and alkaline phosphatase staining were used to observe calcium nodule formation.
RESULTS AND CONCLUSION: Flow cytometry showed high expression levels of CD29 and CD90 and low expression of CD45, with a positive STRO-1 expression rate of 12.8%. Immunofluorescence results were consistent with those of flow cytometry. After magnetic cell sorting, STRO-1 positive cells demonstrated a higher colony formation rate than STRO-1 negative cells. On day 14, STRO-1 positive cells showed significantly higher osteogenic differentiation potential than on day 7, with significantly elevated osteogenesis-related marker levels compared to STRO-1 negative cells (P < 0.01). The findings indicate that STRO-1 positive bone marrow mesenchymal stem cells exhibit significant advantages in osteogenic potential, providing a theoretical basis for their selection as ideal seed cells in bone tissue engineering. In future applications, they may represent a promising therapeutic approach for bone defect repair.

Key words: STRO1, bone marrow mesenchymal stem cells, osteogenic differentiation, immunomagnetic cell sorting, bone defect repair, seed cells, bone tissue engineering, engineered stem cells


分享到:

Publishing Information

Publishing House of Chinese Journal of Tissue Engineering Research


The Official Publication of

Chinese Association of Rehabilitation Medicine

Contact Us

General editorial enquiries:

Email: bwb01@crter.org

Copyright related contact:

Email: crter@crter.org

Commercial Sales contact (Reprints, advertising, etc.):

Email: bwb@crter.org